Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 24.
doi: 10.1007/s00405-024-09181-z. Online ahead of print.

European clinical practice guideline: managing and treating laryngopharyngeal reflux disease

Affiliations

European clinical practice guideline: managing and treating laryngopharyngeal reflux disease

Jerome R Lechien et al. Eur Arch Otorhinolaryngol. .

Erratum in

  • Correction: European clinical practice guideline: managing and treating laryngopharyngeal reflux disease.
    Lechien JR, Chiesa-Estomba CM, Hans S, Nacci A, Schindler A, Bohlender JE, Runggaldier D, Crevier-Buchman L, Oguz H, Zelenik K, Tedla M, Siupsinskiene N, Schlömicher-Thier J, Taimrova R, Karkos PD, Geneid A, Dapri G, Aoun J, Muls V, Weitzendorfer M, Savarino EV, Remacle MJ, Sereg-Bahar M, Mayo-Yanez M, Iannella G, Saibene AM, Vaira LA, Cammaroto G, Maniaci A, Barillari MR. Lechien JR, et al. Eur Arch Otorhinolaryngol. 2025 Mar 27. doi: 10.1007/s00405-025-09307-x. Online ahead of print. Eur Arch Otorhinolaryngol. 2025. PMID: 40148590 No abstract available.

Abstract

Objective: To propose a European consensus for managing and treating laryngopharyngeal reflux disease (LPRD) to guide primary care and specialist physicians.

Methods: Twenty-three European experts (otolaryngologists, gastroenterologists, surgeons) participated in a modified Delphi process to revise 38 statements about the definition, clinical management, and treatment of LPRD. Three voting rounds were conducted on a 5-point scale and a consensus was defined a priori as agreement by 80% of the experts.

Results: After the third round, 36 statements composed the first European Consensus Report on the definition, diagnosis, and treatment of LPRD. The hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring is the gold standard for diagnosing LPRD (> 1 pharyngeal reflux event) and treating the LPRD with personalized therapy. The empirical treatment needs to be based on diet, stress reduction, and alginates or antiacids to address the acidic and alkaline reflux events. Proton pump inhibitors are kept for patients with acidic LPRD and gastroesophageal reflux disease (GERD) findings. The treatment needs to be as short as possible (minimum two months). The medication can be progressively reduced for patients with relief of symptoms. Changing medication class can be considered for refractory LPRD rather than an increase in drug doses.

Conclusion: A consensus endorsed by the Confederation of European Otorhinolaryngology-Head and Neck Surgery Societies is presented to improve the management and treatment of LPRD. The approved statements could improve collaborative research through the adoption of common management approaches to LPRD.

Keywords: Consensus; Europe; European; Gastroesophageal; Guidelines; Head neck surgery; Laryngopharyngeal; Otolaryngology; Reflux.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethic committee: No IRB approval was required for this study protocol. Informed consent: Participants consented to the study. Competing interests: The author Jerome R. Lechien was not involved with the peer review process of this article.

References

    1. Lechien JR, Vaezi MF, Chan WW, Allen JE, Karkos PD, Saussez S, Altman KW, Amin MR, Ayad T, Barillari MR, Belafsky PC, Blumin JH, Johnston N, Bobin F, Broadhurst M, Ceccon FP, Calvo-Henriquez C, Eun YG, Chiesa-Estomba CM, Crevier-Buchman L, Clarke JO, Dapri G, Eckley CA, Finck C, Fisichella PM, Hamdan AL, Hans S, Huet K, Imamura R, Jobe BA, Hoppo T, Maron LP, Muls V, O’Rourke AK, Perazzo PS, Postma G, Prasad VMN, Remacle M, Sant’Anna GD, Sataloff RT, Savarino EV, Schindler A, Siupsinskiene N, Tseng PH, Zalvan CH, Zelenik K, Fraysse B, Bock JM, Akst LM, Carroll TL (2024) The Dubai Definition and Diagnostic Criteria of Laryngopharyngeal Reflux: the IFOS Consensus. Laryngoscope 134(4):1614–1624. https://doi.org/10.1002/lary.31134 - DOI - PubMed
    1. Kotby MN, Hassan O, El-Makhzangy AM, Farahat M, Shadi M, Milad P (2010) Gastroesophageal reflux/laryngopharyngeal reflux disease: a critical analysis of the literature. Eur Arch Otorhinolaryngol 267(2):171–179. https://doi.org/10.1007/s00405-009-1176-4 - DOI - PubMed
    1. Lee YS, Choi SH, Son YI, Park YH, Kim SY, Nam SY (2011) Prospective, observational study using rabeprazole in 455 patients with laryngopharyngeal reflux disease. Eur Arch Otorhinolaryngol 268(6):863–869. https://doi.org/10.1007/s00405-010-1475-9 - DOI - PubMed
    1. Lechien JR, Saussez S, Hopkins C (2023) Association between laryngopharyngeal reflux, gastroesophageal reflux and recalcitrant chronic rhinosinusitis: a systematic review. Clin Otolaryngol 48(4):501–514. https://doi.org/10.1111/coa.14047 - DOI - PubMed
    1. Eren E, Arslanoğlu S, Aktaş A, Kopar A, Ciğer E, Önal K, Katılmiş H (2014) Factors confusing the diagnosis of laryngopharyngeal reflux: the role of allergic rhinitis and inter-rater variability of laryngeal findings. Eur Arch Otorhinolaryngol 271(4):743–747. https://doi.org/10.1007/s00405-013-2682-y - DOI - PubMed

LinkOut - more resources